Variant report
Variant | nsv525808 |
---|---|
Chromosome Location | chr8:112579771-112616415 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572809320 | chr8:112593605-112593606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73329965 | chr8:112593651-112593652 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs558448219 | chr8:112593667-112593668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187424609 | chr8:112593668-112593669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189297209 | chr8:112593672-112593673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563418982 | chr8:112593674-112593675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12541903 | chr8:112593681-112593682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542448918 | chr8:112593708-112593709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559113387 | chr8:112593710-112593711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs180975421 | chr8:112593746-112593747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544904448 | chr8:112593749-112593750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564796555 | chr8:112593771-112593772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77467730 | chr8:112597018-112597019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573285670 | chr8:112597027-112597028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs111519293 | chr8:112597034-112597035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558803497 | chr8:112597040-112597041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575669122 | chr8:112597048-112597049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544510743 | chr8:112597090-112597091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567580993 | chr8:112597126-112597127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192989255 | chr8:112597213-112597214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140943423 | chr8:112597237-112597238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545015679 | chr8:112597280-112597281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538026576 | chr8:112597301-112597302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs150185301 | chr8:112597314-112597315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560371929 | chr8:112597336-112597337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76234602 | chr8:112597342-112597343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552129395 | chr8:112597350-112597351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565146058 | chr8:112597352-112597353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568894270 | chr8:112597368-112597369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141069010 | chr8:112597370-112597371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144820813 | chr8:112597397-112597398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547587427 | chr8:112597398-112597399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138664839 | chr8:112597433-112597434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533936526 | chr8:112597443-112597444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554121881 | chr8:112597444-112597445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369929792 | chr8:112597550-112597551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7013456 | chr8:112597601-112597602 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs558892575 | chr8:112597699-112597700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575690331 | chr8:112597712-112597713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544689137 | chr8:112597713-112597714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554595136 | chr8:112597732-112597733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574700963 | chr8:112597755-112597756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540400839 | chr8:112597797-112597798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34597469 | chr8:112597802-112597803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs538740264 | chr8:112597808-112597809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185228871 | chr8:112597836-112597837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs141667514 | chr8:112597866-112597867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562503767 | chr8:112597880-112597881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531164828 | chr8:112597881-112597882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189443049 | chr8:112597898-112597899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:112593600-112593800 | Enhancers | Pancreas | Pancrea |
2 | chr8:112597000-112598400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr8:112611000-112611800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr8:112611400-112612000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr8:112611600-112611800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr8:112611600-112612200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr8:112611800-112612000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr8:112611800-112612800 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
9 | chr8:112615400-112615800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |